UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Advances in cancer immunotherapy 2019 - latest trends

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.268-268, Article 268

2019

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

BMC cancer, 2008-03, Vol.8 (1), p.82-82, Article 82

2008

Link zum Volltext

Verfügbarkeit prüfen

Systemic treatment of advanced pancreatic cancer

Cancer treatment reviews, 2012-11, Vol.38 (7), p.843-853

2012

Link zum Volltext

Verfügbarkeit prüfen

Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030

Cancer medicine (Malden, MA), 2016-09, Vol.5 (9), p.2649-2656

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Oncoimmunology, 2017-05, Vol.6 (5), p.e1310358-e1310358

2017

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia

Endocrine-related cancer, 2019-03, Vol.26 (3), p.293-301

2019

Link zum Volltext

Verfügbarkeit prüfen

Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater

Surgery, 2015-07, Vol.158 (1), p.151-161

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy

Journal of cancer research and clinical oncology, 2013-04, Vol.139 (4), p.681-689

2013

Link zum Volltext

Verfügbarkeit prüfen

Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients

European journal of cancer (1990), 2014-07, Vol.50 (11), p.1855-1863

2014

Link zum Volltext

Verfügbarkeit prüfen

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

International journal of molecular sciences, 2017-05, Vol.18 (5), p.1094

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for surgical complications in distal pancreatectomy

The American journal of surgery, 2010-09, Vol.200 (3), p.311-317

2010

Link zum Volltext

Verfügbarkeit prüfen

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood

Biomedicines, 2022-09, Vol.10 (10), p.2405

2022

Link zum Volltext

Verfügbarkeit prüfen

Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood

Biomedicines, 2022-10, Vol.10 (10), p.2534

2022

Link zum Volltext

Verfügbarkeit prüfen

Preanalytical Variables in the Analysis of Mitochondrial DNA in Whole Blood and Plasma from Pancreatic Cancer Patients

Diagnostics (Basel), 2022-08, Vol.12 (8), p.1905

2022

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer

Journal of gastroenterology, 2013-04, Vol.48 (4), p.544-548

2013

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer

Cancers, 2021-11, Vol.13 (22), p.5732

2021

Link zum Volltext

Verfügbarkeit prüfen

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate

European journal of cancer (1990), 2018-05, Vol.95, p.109-111

2018

Link zum Volltext

Verfügbarkeit prüfen

Importance of performance status for treatment outcome in advanced pancreatic cancer

World journal of gastroenterology : WJG, 2007-01, Vol.13 (2), p.224

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis

Radiation oncology (London, England), 2018-05, Vol.13 (1), p.93-93, Article 93

2018

Link zum Volltext

Verfügbarkeit prüfen

UGT1A1 gene polymorphism： Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer

World journal of gastroenterology : WJG, 2009-10, Vol.15 (40), p.5058-5066

2009

Link zum Volltext

Verfügbarkeit prüfen

Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020-09, Vol.20 (6), p.1131-1138

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer

Journal of gastrointestinal surgery, 2017-11, Vol.21 (11), p.1775-1783

2017

Link zum Volltext

Verfügbarkeit prüfen

Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts

World journal of gastroenterology : WJG, 2014-08, Vol.20 (31), p.10769-10777

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 495

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(454)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(266)
Deutsch
(250)
Japanisch
(30)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(175)
Life Sciences & Biomedicine
(139)
Humans
(118)
Oncology
(73)
Male
(67)
Female
(66)
Middle Aged
(65)
Pancreatic Cancer
(64)
Aged
(50)
Pancreatic Neoplasms - Drug Therapy
(48)
Adult
(44)
Pancreatic Neoplasms - Pathology
(37)
Chemotherapy
(36)
Prognosis
(29)
Medicine
(28)
Deoxycytidine - Analogs & Derivatives
(27)
Deutschland
(27)
Technology
(26)
Aged, 80 And Over
(25)
Medicine & Public Health
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Advances in cancer immunotherapy 2019 - latest trends

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

Systemic treatment of advanced pancreatic cancer

Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia

Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy

Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

Risk factors for surgical complications in distal pancreatectomy

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood

Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood

Preanalytical Variables in the Analysis of Mitochondrial DNA in Whole Blood and Plasma from Pancreatic Cancer Patients

KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer

Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate

Importance of performance status for treatment outcome in advanced pancreatic cancer

Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis

UGT1A1 gene polymorphism： Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer

Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer

Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts

Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer

Suchergebnisse filtern